ACTIVITY OF AMPICILLIN SULBACTAM, TICARCILLIN/CLAVULANATE, CLARITHROMYCIN, AND 11 OTHER ANTIMICROBIAL AGENTS AGAINST ANAEROBIC-BACTERIA ISOLATED FROM INFECTIONS IN CHILDREN/
Dm. Citron et al., ACTIVITY OF AMPICILLIN SULBACTAM, TICARCILLIN/CLAVULANATE, CLARITHROMYCIN, AND 11 OTHER ANTIMICROBIAL AGENTS AGAINST ANAEROBIC-BACTERIA ISOLATED FROM INFECTIONS IN CHILDREN/, Clinical infectious diseases, 20, 1995, pp. 356-360
The activity of 14 antimicrobial agents against 253 clinical isolates
of anaerobic bacteria from pediatric infections was assessed by the ag
ar dilution method. Fifty-eight percent of the isolates were from intr
aabdominal sites. The drugs tested were ampicillin/sulbactam, ticarcil
lin/clavulanate, ampicillin, sulbactam, piperacillin, cefoxitin, cefot
axime, cefoperazone/sulbactam, clarithromycin, azithromycin, erythromy
cin, clindamycin, metronidazole, and chloramphenicol. Ticarcillin/clav
ulanate was active against an isolates. Clarithromycin was the most ac
tive macrolide; combination of this agent with its 14-hydroxy metaboli
te did not result in synergy. Sixty-two percent of Bacteroides fragili
s group isolates, 13% of B. fragilis isolates, and 22% of peptostrepto
coccal isolates were resistant to clindamycin at a concentration of 4
mu g/mL. The distribution of these strains in clinical specimens and t
he patterns of antimicrobial susceptibility documented were different
from the findings for isolates from adults in the Los Angeles area,